762315004: Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder)

SNOMED CT Concept\Clinical finding\...

\Mass of body structure\Mass of lymphoreticular structure\Neoplasm of bone marrow\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Mass of body structure\Mass of lymphoreticular structure\Neoplasm of bone marrow\Acute leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Mass of body structure\Haematologic neoplasm\Neoplasm affecting haematopoietic structure\Leukaemia\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Mass of body structure\Haematologic neoplasm\Neoplasm affecting haematopoietic structure\Leukaemia\Acute leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent

\Disease\Complication of chemotherapy\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of haematopoietic morphology\Myeloproliferative disorder\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Neoplasm and/or hamartoma\Neoplastic disease\Neoplasm of haematopoietic cell type\Malignant tumour of lymphoid haemopoietic and related tissue\Leukaemia\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Neoplasm and/or hamartoma\Neoplastic disease\Neoplasm of haematopoietic cell type\Malignant tumour of lymphoid haemopoietic and related tissue\Leukaemia\Acute leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Neoplasm and/or hamartoma\Neoplastic disease\Malignant neoplastic disease\Malignant tumour of lymphoid haemopoietic and related tissue\Leukaemia\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Neoplasm and/or hamartoma\Neoplastic disease\Malignant neoplastic disease\Malignant tumour of lymphoid haemopoietic and related tissue\Leukaemia\Acute leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Neoplasm and/or hamartoma\Neoplastic disease\Neoplastic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Neoplasm and/or hamartoma\Neoplastic disease\Haematologic neoplasm\Neoplasm affecting haematopoietic structure\Leukaemia\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Neoplasm and/or hamartoma\Neoplastic disease\Haematologic neoplasm\Neoplasm affecting haematopoietic structure\Leukaemia\Acute leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of body system\Disorder of haematopoietic structure\Neoplasm affecting haematopoietic structure\Leukaemia\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of body system\Disorder of haematopoietic structure\Neoplasm affecting haematopoietic structure\Leukaemia\Acute leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of body system\Disorder of haematopoietic structure\Bone marrow disorder\Myeloproliferative disorder\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of body system\Disorder of haematopoietic structure\Bone marrow disorder\Neoplasm of bone marrow\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of body system\Disorder of haematopoietic structure\Bone marrow disorder\Neoplasm of bone marrow\Acute leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of body system\Haematologic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of body system\Haematologic neoplasm\Neoplasm affecting haematopoietic structure\Leukaemia\Myeloid leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder of body system\Haematologic neoplasm\Neoplasm affecting haematopoietic structure\Leukaemia\Acute leukaemia\Acute myeloid leukemia, disease\Therapy related acute myeloid leukaemia and myelodysplastic syndrome\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder following clinical procedure\Neoplastic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Disorder following clinical procedure\Haematologic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Complication of procedure\Neoplastic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Complication of procedure\Haematologic complication of procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Complication of procedure\Complication of introduction procedure\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent
\Disease\Drug-induced lesion\Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent

Status: current, Defined. Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3635334012 Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent en Synonym Active Case insensitive SNOMED CT core

3636381018 Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder) en Fully specified name Active Case insensitive SNOMED CT core

3636382013 Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent en Synonym Active Case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Disorder following clinical procedure	false	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Complication of introduction procedure	true	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Drug-induced lesion	true	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Haematologic complication of procedure	true	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Neoplastic complication of procedure	true	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Due to	Administration of antineoplastic agent	true	Inferred relationship	Some	1
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Drug-related disorder	false	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Complication of procedure	false	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Sequela	false	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Complication of chemotherapy	true	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Is a	Therapy related acute myeloid leukaemia and myelodysplastic syndrome	true	Inferred relationship	Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Following	Administration of antineoplastic agent	true	Inferred relationship	Some	2
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Associated morphology	Therapy-related acute myeloid leukaemia and myelodysplastic syndrome	true	Inferred relationship	Some	3
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Causative agent	Antineoplastic agent	true	Inferred relationship	Some	3
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Finding site	Bone marrow structure	true	Inferred relationship	Some	3

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent	Is a	True	Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	Inferred relationship	Some

Reference Sets

Australian emergency department reference set

Clinical finding foundation reference set

Neoplasm and/or hamartoma reference set

Problem/Diagnosis reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3635334012	Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent	en	Synonym	Active	Case insensitive	SNOMED CT core
3636381018	Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3636382013	Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent	en	Synonym	Active	Case insensitive	SNOMED CT core